These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 23773943)

  • 21. ACP Journal Club. Meta-analysis: Atorvastatin reduces CV events and increases new-onset diabetes in patients with coronary disease.
    Sethi SS; Farkouh ME
    Ann Intern Med; 2013 Jul; 159(2):JC3. PubMed ID: 23856701
    [No Abstract]   [Full Text] [Related]  

  • 22. High-dose statins and the IDEAL study.
    Ravnskov U; Rosch PJ; Sutter MC
    JAMA; 2006 Jun; 295(21):2476; author reply 2478-9. PubMed ID: 16757714
    [No Abstract]   [Full Text] [Related]  

  • 23. High-dose statins and the IDEAL study.
    Cayley WE
    JAMA; 2006 Jun; 295(21):2476; author reply 2478-9. PubMed ID: 16757713
    [No Abstract]   [Full Text] [Related]  

  • 24. High-dose statins and the IDEAL study.
    Ong HT; Cheah JS
    JAMA; 2006 Jun; 295(21):2476-7; author reply 2478-9. PubMed ID: 16757712
    [No Abstract]   [Full Text] [Related]  

  • 25. Statin therapy after stroke or transient ischemic attack.
    Cohen JS
    N Engl J Med; 2006 Nov; 355(22):2368; author reply 2370-1. PubMed ID: 17135593
    [No Abstract]   [Full Text] [Related]  

  • 26. Intensive lipid lowering with atorvastatin in coronary disease.
    Cannon CP; Murphy SA; Braunwald E
    N Engl J Med; 2005 Jul; 353(1):93-6; author reply 93-6. PubMed ID: 16003832
    [No Abstract]   [Full Text] [Related]  

  • 27. Impact of out-of-pocket expenses on discontinuation of statin therapy: a cohort study in Finland.
    Helin-Salmivaara A; Korhonen MJ; Alanen T; Huupponen R
    J Clin Pharm Ther; 2012 Feb; 37(1):58-64. PubMed ID: 21410736
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Not a graves' situation.
    Ruchala M; Szczepanek E; Puszczewicz M; Sosnowski P; Sowinski J
    Am J Med; 2011 Mar; 124(3):210-4. PubMed ID: 21396501
    [No Abstract]   [Full Text] [Related]  

  • 29. Discontinuation of statin therapy and clinical outcome after ischemic stroke.
    Colivicchi F; Bassi A; Santini M; Caltagirone C
    Stroke; 2007 Oct; 38(10):2652-7. PubMed ID: 17761916
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug utilization patterns and cardiovascular outcomes in elderly patients newly initiated on atorvastatin or simvastatin.
    Swindle JP; Potash J; Kulakodlu M; Kuznik A; Buikema A
    Am J Geriatr Pharmacother; 2011 Dec; 9(6):471-82. PubMed ID: 22019005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tachyphylaxis and statin drugs.
    Stein JH; McBride PE
    Am J Cardiol; 2001 Mar; 87(5):674. PubMed ID: 11245286
    [No Abstract]   [Full Text] [Related]  

  • 32. [Ezetimib plus statin combination. A strong duo].
    MMW Fortschr Med; 2002 Nov; 144(48):53. PubMed ID: 12532547
    [No Abstract]   [Full Text] [Related]  

  • 33. The efficacy of statin monotherapy uptitration versus switching to ezetimibe/simvastatin: results of the EASEGO study.
    Roeters van Lennep HW; Liem AH; Dunselman PH; Dallinga-Thie GM; Zwinderman AH; Jukema JW
    Curr Med Res Opin; 2008 Mar; 24(3):685-94. PubMed ID: 18226326
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Acute cholestatic hepatitis after atorvastatin reintroduction].
    de Castro ML; Hermo JA; Baz A; de Luaces C; Pérez R; Clofent J
    Gastroenterol Hepatol; 2006 Jan; 29(1):21-4. PubMed ID: 16393626
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Are statins created equal? Evidence from randomized trials of pravastatin, simvastatin, and atorvastatin for cardiovascular disease prevention.
    Zhou Z; Rahme E; Pilote L
    Am Heart J; 2006 Feb; 151(2):273-81. PubMed ID: 16442888
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatotoxicity associated with statins: reports of idiosyncratic liver injury post-marketing.
    Björnsson E; Jacobsen EI; Kalaitzakis E
    J Hepatol; 2012 Feb; 56(2):374-80. PubMed ID: 21889469
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dose-related effect of statins on atrial fibrillation after cardiac surgery.
    Kourliouros A; De Souza A; Roberts N; Marciniak A; Tsiouris A; Valencia O; Camm J; Jahangiri M
    Ann Thorac Surg; 2008 May; 85(5):1515-20. PubMed ID: 18442529
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A large observational study of cardiovascular outcomes associated with atorvastatin or simvastatin therapy in hypertensive patients without prior cardiovascular disease.
    Foody JM; Joyce AT; Jeffers BW; Liu LZ; Benner JS
    Am J Ther; 2011; 18(2):110-6. PubMed ID: 20216383
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of high-intensity statin therapy with simvastatin 80 mg and atorvastatin 80 mg in primary care.
    Meek CL; Reston JD; Ramsbottom T; Pathmanathan H; Viljoen A
    Int J Clin Pract; 2011 Feb; 65(2):120-6. PubMed ID: 21235694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased skeletal muscle mitochondrial DNA in patients treated with high-dose simvastatin.
    Schick BA; Laaksonen R; Frohlich JJ; Päivä H; Lehtimäki T; Humphries KH; Côté HC
    Clin Pharmacol Ther; 2007 May; 81(5):650-3. PubMed ID: 17329991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.